PofoliaShared via Pofolia

Journal of Managed Care Pharmacy· 2012

Dosing Frequency and Medication Adherence in Chronic Disease

Craig I Coleman, Brendan Limone, Diana M Sobieraj, Soyon Lee et al.

Short summary

Once-daily medication regimens significantly improve patient adherence compared to more frequent dosing schedules in chronic disease patients, with adherence rates dropping by up to 54.2% for 4-times-daily schedules.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Once-daily medication regimens are associated with significantly higher adherence rates in chronic disease patients compared to multi-daily regimens.
  • Adherence rates decrease progressively with increased dosing frequency: -6.7% (2x/day), -13.5% (3x/day), and -19.2% (4x/day) for 'taking adherence'.
  • The most stringent adherence measure, 'timing adherence,' showed the largest drops: -26.7% (2x/day), -39.0% (3x/day), and -54.2% (4x/day) compared to once-daily.
  • The study utilized a multivariate linear mixed-model meta-regression analysis of 51 studies.

AI-generated from the title and abstract; the full text is not read.

Abstract

BACKGROUND: Prior research has shown a decrease in medication adherence as dosing frequency increases; however, meta-analyses have not been able to demonstrate a significant inverse relationship between dosing frequency and adherence when comparing twice-daily versus once-daily dosing. OBJECTIVE: To determine the effect of scheduled dosing frequency on medication adherence in patients with chronic diseases. METHODS: A systematic literature search of Medline and Embase from January 1986 to December 2011 and a hand search of references were performed to identify eligible studies. Randomized and observational studies were included if they utilized a prospective design, assessed adult patients with chronic diseases, evaluated scheduled oral medications taken 1 to 4 times daily, and measured medication adherence for at least 1 month using an electronic monitoring device. Manual searches of reference sections of identified studies and systematic reviews were also performed to find other potentially relevant articles. Standard definitions for medication taking, regimen, and timing adherence were used and evaluated. Studies were pooled using a multivariate linear mixed-model method to conduct meta-regression accounting for both random and fixed effects, weighted by the inverse of the variance of medication adherence. RESULTS: Fifty-one studies, comprising 65, 76, and 47 dosing frequency arms for the taking, regimen, and timing adherence endpoints were included. Unadjusted adherence estimates were highest when the least stringent definition, taking adherence, was used (range for dosing frequencies: 80.1%-93.0%) and lowest when the most stringent definition, timing adherence, was used (range for dosing frequencies: 18.8%-76.9%). In multivariate meta-regression analyses, the adjusted weighted mean percentage adherence rates for all regimens dosed more frequently than once per day were significantly lower compared with once-daily regimens (for 2-times, 3-times, and 4-times daily regimens, respectively: differences for taking adherence: -6.7%, -13.5%, and -19.2%; regimen adherence: -13.1%, -24.9%, and -23.1%; and timing adherence: -26.7%, -39.0%, and -54.2%). CONCLUSION: Patients with chronic diseases appear to be more adherent with once-daily compared with more frequently scheduled medication regimens. The use of more stringent definitions of adherence magnified these findings.

The authors' abstract, as published at the source. Journal of Managed Care Pharmacy, 2012 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Family Practice

Family PracticeMedicine